跳至主要内容
临床试验/NCT05470049
NCT05470049Unknown2 期

A Phase II, Randomized, Double-Blind Study of the Combination of SHR8554 Injection and SHR0410 Injection for the Treatment of Pain After Abdominal Surgery.

Jiangsu HengRui Medicine Co., Ltd.0 个研究点目标入组 108 人开始时间: 2022年8月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
入组人数
108
主要终点
the Sum of Pain Intensity Differences in Pain Score Over 24 Hours

研究概览

简要总结

The primary objective is to evaluate the analgesic efficacy of the combination of SHR8554 injection and SHR0410 injection compared with SHR8554 injection in patients with acute postoperative pain following abdominal surgery

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Able and willing to provide a written informed consent
  • Subjects requiring elective general anesthesia abdominal surgery
  • Conform to the ASA Physical Status Classification

排除标准

  • Subjects with a history of difficult airway
  • Subjects with a history of reflux esophagitis
  • Subjects with a history of mental illness
  • Subjects with poor blood pressure control
  • Random blood glucose ≥11.1mmol/L
  • Subjects with abnormal liver function
  • allergies to opioids and other medications that may be used during the trial
  • The investigators determined that other conditions were inappropriate for participation in this clinical trial

研究组 & 干预措施

Treatment group A: SHR8554 Injection and SHR0410 Injection

Experimental

干预措施: SHR8554 Injection and SHR0410 Injection (Drug)

Treatment group B: SHR8554 Injection and SHR0410 Injection

Experimental

干预措施: SHR8554 Injection and SHR0410 Injection (Drug)

Treatment group C: SHR8554 Injection and Placebo for SHR0410 Injection

Placebo Comparator

干预措施: SHR8554 Injection and Placebo for SHR0410 Injection (Drug)

结局指标

主要结局

the Sum of Pain Intensity Differences in Pain Score Over 24 Hours

时间窗: 24-hours

Pain intensity will be evaluated using an 11-point (0-10) Numeric Pain Rating Scale (NPRS), with higher numbers indicating a higher pain intensity, administered over 24 hours. Time weighted average change from baseline is calculated using the following: time weighted sum of pain intensity differences (SPID) divided by a constant (24 hours) to yield values on the 0-10 NPRS.

次要结局

  • the Sum of Pain Intensity Differences in Pain Score Over 6、12、12-24 Hours(6-hours、12-hours、12-24 hours)
  • Time of first use of remedial analgesic medication(24-hours)
  • Cumulative use of remedial analgesics from 0h to 24h(24-hours)
  • Participant ' satisfaction score for analgesia treatment(24-hours)
  • Investigator satisfaction score for analgesia treatment(24-hours)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验